fda warning bpc-157 october 2025 BPC 157 Banned: Key Facts on the Latest Decision FDA staff have raised concerns

Sewell-LoftinMKBayerSVHCristEHughesTJoisonSMLongmoreGDet al

BPC-157 is supplied strictly as a research compound for in-vitro and laboratory use

However, its clinical application must be approached with a critical and nuanced understanding of the current evidence gap

Site rotation (abdomen, thighs, upper arms) is the commonly reported approach to reduce this reaction

Peptides for muscle growth are gaining attention as a potential tool for increasing lean mass, accelerating recovery and enhancing body composition

The result: Increased lipolysis : Fat cells release stored fatty acids for use as fuel Inhibited lipogenesis : Dietary fats are less readily converted to stored body fat No significant IGF-1 stimulation : Means no growth of existing tumors or cancer risk amplification that concerns some clinicians with full GH No significant glucose disruption : Unlike full HGH, which causes insulin resistance at therapeutic doses, AOD-9604 shows minimal glucose impact in studies This makes it uniquely well-suited for fat loss use cases where full HGH would be too blunt an instrument